Compare ARK Genomic Revolution ETF (ARKG) vs Global X Robotics and Artificial Intelligence ETF (BOTZ) Price & Performance
Price performance
Price movement over the last 24 hours
Key statistics
Key statistics
ARK Genomic Revolution ETF vs Global X Robotics and Artificial Intelligence ETF — how do they compare? ARK Genomic Revolution ETF trades at $41.25, while Global X Robotics and Artificial Intelligence ETF trades at $36.39. The key difference: ARK Genomic Revolution ETF is trading nearer its 52-week high, Global X Robotics and Artificial Intelligence ETF nearer its low. Which is the better fit depends on your goals.
| ARKG | BOTZ | |
|---|---|---|
Sector | Sector/Thematic | — |
52-Week High | $43.57 | $41.63 |
52-Week Low | $23.09 | $31.99 |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
ARKG trades at $41.32, down 3.91% today, with a bullish technical signal driven by moving averages. Recent news highlights biotech ETF strength in June 2026, fueled by strong earnings, M&A activity, and AI-driven drug discovery optimism. Key support lies at $40, with resistance at $44.
The outlook remains positive given sector tailwinds, but risks include regulatory hurdles and market volatility. Investor sentiment is buoyed by industry growth catalysts, though selective investment approaches are noted by analysts.
BOTZ trades at $36.91, up 0.76% today, but faces a bearish technical outlook with moving averages signaling strong selling pressure. The robotics and AI ETF benefits from growing investor interest in physical AI applications, with recent news highlighting humanoid robotics as the next trillion-dollar opportunity. However, key financial ratios remain unavailable for analysis.
The ETF's outlook is supported by accelerating robotics adoption but challenged by technical weakness. Investment opportunity lies in the structural shift toward automation, while risks include market volatility and concentrated sector exposure. The neutral oscillator readings suggest potential for near-term consolidation.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
About ARK Genomic Revolution ETF
ARKG is an actively managed ETF that invests in the genomic revolution. It focuses on companies leading in gene editing, CRISPR technology, therapeutics, and molecular diagnostics, including firms like CRISPR Therapeutics and Tempus AI.
Read more on ARKG →About Global X Robotics and Artificial Intelligence ETF
The fund invests at least 80% of its total assets in the securities of the underlying index. The underlying index is designed to provide exposure to exchange-listed companies in developed markets that are involved in the development of robotics and/or artificial intelligence. The fund is non-diversified.
Read more on BOTZ →
